Brief: Pliant Therapeutics Amendment To May 2022 $100 Million Loan Facility With Oxford Finance, Upsizing Facility To $150 Million Of Available Non-Dilutive Capital

Pliant Therapeutics

12/03/2024 11:49

March 12 (Reuters) - Pliant Therapeutics Inc  PLRX.O :
    * PLIANT THERAPEUTICS: AMENDMENT TO MAY 2022 $100 MILLION
LOAN
FACILITY WITH OXFORD FINANCE, UPSIZING FACILITY TO $150 MILLION
OF AVAILABLE NON-DILUTIVE CAPITAL
    * PLIANT THERAPEUTICS INC: LOAN FACILITY, ALONG WITH CO'S
DEC 31,
2023 CASH & CASH EQUIVALENTS OF $495.7 MILLION ARE EXPECTED TO
FUND PLIANT THROUGH 2026
    * PLIANT THERAPEUTICS INC: IMPLEMENTATION OF BEACON-IPF AS A
PIVOTAL, ADAPTIVE PHASE 2B/3 TRIAL IN PATIENTS WITH IDIOPATHIC
PULMONARY FIBROSIS

Source text for Eikon:  ID:nGNX5BMvJR 
Further company coverage:  PLRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))